We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

The Power of Positrons: PET/CT Advances Preclinical Pharmaceutical Research

Industry Insight   Feb 18, 2020 | By Todd Sasser, Bruker

The Power of Positrons: PET/CT Advances Preclinical Pharmaceutical Research

Preclinical images of mice using Si78 low does PET/CT. (Bruker BioSpin) Credit: Bruker

 
 
Advertisement
 
 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE